- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 169
Snap quickens pace to 2017 IPO
Snap, formerly known as Snapchat and backed by Alibaba, Tencent and Yahoo, is preparing an offering that could value it at $25bn and take place as early as March.
Oct 7, 2016Nutanix processes flotation
The cloud enterprise platform, backed by Sapphire Ventures, is set to make its debut on Nasdaq today after securing nearly $238m in an initial public offering yesterday.
Sep 30, 2016ForeScout Technologies explores flotation
Itochu and Intel-backed cybersecurity company ForeScout has entered talks with investment banks to underwrite an IPO that could value it at up to $1bn.
Sep 27, 2016Nokia exits Gridsum in $87m IPO
China-based data analysis software producer Gridsum Holding has floated in the US, giving exits to Nokia Growth Partners and Disney affiliate Steamboat Ventures.
Sep 27, 2016Apptio manages $96m IPO
The business management software producer floated above its range in an offering that allowed Cisco to exit, and which could reach $110m in size.
Sep 26, 2016Novan cleans up in $45m IPO
The Malin-backed dermatology treatment developer floated at the bottom of its range, but is currently 65% up after its first day of trading.
Sep 22, 2016Uzabase to touch down on public markets
The company database and news app operator, backed by GMO, Yahoo Japan, Itochu and Kodansha, will float in its home country of Japan next month.
Sep 19, 2016Crispr plays it cool with IPO filing
Existing backer Bayer will invest $35m through a private placement alongside an initial public offering in which the gene editing company is initially looking to raise $90m.
Sep 13, 2016Apptio to plan out $75m IPO
The Cisco-backed IT business management software producer has raised more than $135m in VC funding
Aug 30, 2016Novan hits nitro for $60m IPO
The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.
Aug 26, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


